|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 慢性乙型肝炎抗病毒耐药及其处理显示文摘Lacarnini教授为国际著名的病毒学家,近年来对乙型肝炎病毒(HBV)耐药性的研究有突出的贡献。他是本刊的国际编委。本文是根据他在2007年3月26日日本京都APASL年会前应邀为中国学者作专题报告的录音整理而成。蒙他同意在本刊发表,以飨读者。 | Locarnini S | 2007 | 肝脏2007，12，3： | 28 |
| 2 | Entecavir for the treatment of chronic hepatitis B 显示文摘 | Shaw T Locarnini S | 2004 | Expert Rev Anti Infect Ther2004，2，6： | 1 |
| 3 | Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management显示文摘 | Lok AS Zoulim F Locarnini S | 2007 | Hepatology2007，46，1： | 1 |
| 4 | Hepatitis B vires resistance to nucleos (t) ide analogues 显示文摘 | ZOULIM F LOCARNINI S | 2009 | Gastroenterology2009，137，： | 1 |
| 5 | Hepatitis B virus surface antigen and polymeraze gene variants:potential viological and clinical significance显示文摘 | LOCARNINI S A | 1998 | Hcpa- tology1998，27，1： | 1 |
| 6 | Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy显示文摘 | Werle-Lapostolle B Bowden S Locarnini S | | 0，，07： | 1 |
| 7 | Antiviralchemotherapy for the treatment of hepatitis B virus显示文摘 | Torresi J Locarnini S | 2000 | Gastroenterology2000，118，： | 1 |
| 8 | Entecavir for the treatment of chronic hepatitis B 显示文摘 | Shaw T Locarnini S | 2004 | Expert Rew Anti Infect Ther2004，2，6： | 1 |
| 9 | HBV mutants associated with clinical resistance to adefovir dip ivoxil disp lay only small decreases in antiviral sensitivity in vitrol显示文摘 | Locarnini S Shaw T Sozzi T | 2004 | Hepatology2004，40，4： | 1 |
| 10 | Primary resistance, muhidrug resistance, and cross-resist- ance pathways in HBV as a consequence of treatment failure显示文摘 | Locarnini S | 2008 | Hep- atol Int2008，2，2： | 1 |
| 11 | Persistence of cccDNA during the natural history of' chronic hepatitis B and declene during adefovir dipivoxil therapy 显示文摘 | Werle- Lapostolle B Bowden S Locarnini S | 2004 | Gastroenterology2004，126，7： | 1 |
| 12 | HBV mutants associated with clinical resistance to adefovir dipivoxil display only small decreases in antiviral sensitivity in vitro显示文摘 | Locarnini S Shaw T Sozzi T | 2004 | Hepatology2004，404，： | 1 |
| 13 | Management of treatment failure in chro- nic hepatitis B 显示文摘 | Zoulim F Locarnini S | 2012 | J Hepatol2012，56，1： | 1 |
| 14 | Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil(ADV) therapy for patients with chronic hepatitis B(CHB)显示文摘 | Locarnini S Qi X Arterburn S Pichoud C Xiong S | 2005 | J Hepatol2005，42，1： | 1 |
| 15 | The distribution of dimethylsulfide,DMS,and dimethylsulfoniopropionate,DSMP,in waters of the Western Coast of Ireland显示文摘 | Sally Jo Palmer Locarnini Turner S M Liss P S | 1998 | Continental Shelf Research1998，18，： | 1 |
| 16 | Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy显示文摘 | Werle-Lapostolle B Bowden S Locarnini S | | 0，，07： | 1 |
| 17 | In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir 显示文摘 | Colledge D Civitico G Locarnini S | 2000 | Antimicrob Agents Chemother2000，44，： | 1 |
| 18 | Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management显示文摘 | Lok AS Zoulim F Locarnini S | 2007 | Hepatology2007，46，1： | 1 |
| 19 | The antiviral drug selected hepatitis B virus rtA181T/sW172 * mutant has a dominant negative secretion defect and alters the typical profile of viral rebound显示文摘 | Warner N Locarnini S | 2008 | Hepatology2008，48，： | 1 |
| 20 | Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy显示文摘 | Werle-Lapostolle B Bowden S Locarnini S | 2004 | Gastroenterology2004，126，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员